ICOSL (inducible T-cell costimulator ligand) expressed on AML cells has induced expansion of both human Treg in vitro and in vivo in mouse model of AML, whereas blockade of ICOSL in vivo partially reversed Treg expansion and slowed down AML progression [184]. This evidence concerns the gene ICOSLG and acute myeloid leukemia.